Buy Ahluwalia Contracts Ltd For Target Rs.708 by Prabhudas Liladhar Capital Ltd
Margin improves QoQ
Ahluwalia reported a sharp sequential margin recovery in Q2FY27. Revenue grew 24.3% YoY, as large projects that started slowly in Q1 picked up. EBITDA margin recovering to 7.6% from 4.3% in Q1, though still well below 10.9% a year ago. Margin remained under pressure from a higher material share on early-stage EPC projects (Central Vista, CSMT), annual increments and higher PF outgo. Management retained 15%+ revenue growth for FY27 and guided 15–20% for FY28 but expects H2FY27 margins to stay around Q2 levels and FY28 margins at 8.5–9%. Order inflow guidance is now INR 40 bn, with ~INR 10 bn won so far. We cut FY28E/FY29E EPS by 16.1%/4.1% on lower margin assumptions and revise our TP to INR 708 at 15x 1HFY28 EPS (from INR 930). We retain BUY, as the stock trades at ~11x average FY28/29E EPS, below its 10-year average of ~19x, while a debt-free balance sheet and a net order book of INR 196.3 bn (~3.9x TTM revenue) support medium-term growth.
Strong execution; margin recovers but stays below last year:
Standalone revenue grew 24.3% YoY and 30.0% QoQ to INR 14,637 mn, taking H1FY27 growth to 18.7%. EBITDA fell 13.8% YoY to INR 1,109 mn, with margin at 7.6% (vs 10.9% YoY / 4.3% QoQ). Material cost rose to 47.0% of revenue from 40.5% a year ago. Management attributed this to project mix: on EPC jobs like Central Vista and CSMT, early billing only just covers material cost, and the material share should fall over the next 6–9 months. Employee cost rose 9.8% YoY to INR 1,326 mn on increments and the higher PF wage ceiling. PAT fell 29.4% YoY to INR 559 mn, also hit by a 56.2% YoY rise in depreciation to INR 348 mn.
Guidance - Revenue on track;margins capped:
Management retained FY27 revenue growth at 15%+ and guided 15–20% for FY28. Q3 revenue is expected at ~INR 13 bn (down ~10% QoQ) as GRAP shuts NCR sites for 1–1.5 months, with Q4 the strongest quarter. H2FY27 EBITDA margin is guided at around the Q2 level, and FY28 at 8.5–9% (at least 1pp higher). Management called double-digit margins hard to forecast, citing the PF change (~50bps margin impact), uncertain cost pass-through and supply-chain volatility. On escalation, about half of clients whose contracts lacked a labour escalation clause have agreed to pay it, and all new bids carry labour and material escalation clauses. Order inflow guidance is INR 40 bn against ~INR 10 bn won so far (YTD INR 5.6 bn plus the ~INR 3.5 bn Bennett University order in October), with INR 15 bn of bids submitted and a ~INR 50 bn pipeline.
Execution and balance sheet:
Central Vista is ramping up, with monthly billing of INR 430 mn in October, rising to ~INR 600 mn in November and INR 600–700 mn in December. That gives ~INR 1.5 bn in Q3 and over INR 2 bn in Q4, and management retained its FY27 target of ~INR 7 bn. CSMT has picked up after design approvals and is guided to ~INR 1.5 bn of billing in Q3 and ~INR 2 bn in Q4. India Jewellery Park is still awaiting the notice to proceed, and no revenue is expected in Q3. The balance sheet remains strong: it is debt-free, with ~INR 10 bn of cash, bank balances and liquid funds. Mobilisation advances stand at INR 9.39 bn (32% interest-bearing), retention at INR 4.37 bn and unbilled revenue at INR 9.25 bn. FY27 capex has been trimmed to ~INR 2.25 bn (H1: INR 1.42 bn), with FY28 at INR 2.2–2.5 bn.
Please refer disclaimer at Report
SEBI Registration number is INH000000933
